COMMUNIQUÉS West-GlobeNewswire

FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
17/09/2026
Innovative gene therapy offers a new option for children with a rare, progressive neurodevelopmental disease Silver Spring, Md., Sept. 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved [...]
AVAVA Announces $45 Million Financing Led by Catalio Capital Management to Accelerate Next Phase of Growth
17/09/2026
$30 Million Equity Financing and $15 Million Debt Facility Support Continued Commercial Expansion, Innovation and Global Growth BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- AVAVA, Inc., a medical aesthetics company [...]
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
17/09/2026
FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the devastating, irreversible neurologic progression and loss of function associated with Sanfilippo syndrome Type A [...]
MAPS Attends Historic FDA Hearing on Psychedelics
17/09/2026
The FDA's Sept. 14 public hearing on the potential future therapeutic use of psychedelic drugs marks one of the most significant regulatory moments for the field. The FDA is accepting written testimony to its docket, [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 15, 2026 it granted stock options to purchase an aggregate of 52,834 shares of [...]
Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
17/09/2026
New Drug Application for azetukalner in focal seizures submitted to U.S. Food and Drug Administration; X-TOLE3 and X-ACKT continue to enroll focal seizure and PGTCS patients, respectively Enrollment in X-NOVA2 study in [...]
argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors
17/09/2026
September 17, 2026 – 22:01PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced the results of the Extraordinary General Meeting of [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/09/2026
WALTHAM, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement
17/09/2026
MINNEAPOLIS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”), a leading cannabis company and agricultural markets platform today announced that, in connection [...]
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
17/09/2026
IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its common stock at a [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
17/09/2026
ZUG, Switzerland, Sept. 17, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachment notification-of-managers-transaction- [...]
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
17/09/2026
EMPAVELI-treated adolescents achieved a 75% relative reduction in proteinuria within 6 months versus placebo EMPAVELI is the only approved treatment for adolescents with C3G and primary IC-MPGN, based on VALIANT study [...]
NOMAD POWER SOLUTIONS FILES EXPANDED BUSINESS AND FINANCIAL DISCLOSURE FOLLOWING COMPLETION OF MERGER
17/09/2026
Filing highlights commercial deployments, strengthened capital position and growing opportunity for rapidly deployable power infrastructure BOCA RATON, Fla, Sept. 17, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions ( [...]
Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)
17/09/2026
LOUISVILLE, Ky., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca for Etcamah™ (camizestrant), which is [...]
Universal Door Meditation Center establishes Thai Pho Mon Awakened Center
17/09/2026
Thai Theravada monk Ajahn Marut donated his ancestral family land in Surat Thani province to the Sugar Land, Texas, organization, 25 years after its founder completed her awakening in Thailand Awakened Zen Master Thich [...]
FemPulse Ring Gains CE Mark Certification for the EU
17/09/2026
VIENNA and SAN FRANCISCO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s FemPulse Ring™ has [...]
VIRBAC: Une marge opérationnelle2 solide de 18,8 %, portée par une croissance soutenue du chiffre d'affaires de +7,4 %
17/09/2026
Le premier semestre 2026 affiche une solide croissance du chiffre d'affaires de +7,4 % et une marge d'EBIT ajusté² de 18,8 % à PCC¹ : La croissance du chiffre d'affaires provient des deux segments : animaux de compagnie [...]
VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%
17/09/2026
H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin 2 of 18.8% at CERS: Revenue growth is coming from both segments : companion animal +10.0% and farm animal +6.7% with a strong contribution [...]
PracticeLink Opens Fall 2026 First Practice Fund Applications
17/09/2026
$2,500 awards support aspiring physicians and advanced practice providers on their journey from training to practice ST. LOUIS and HINTON, West Virginia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- PracticeLink today announced [...]

Pages